Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

NASDAQ:LGND   4:00:00 PM EDT
72.90
+1.43 (+2.00%)
4:09:32 PM EDT: $72.90 0.00 (0.00%)
Earnings Announcements

Ligand Pharmaceuticals Says Quarterly Diluted Net Income Per Share $0.02

Published: 11/07/2022 21:41 GMT
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B (LGND) - Qtrly Diluted Net Income per Share $0.02 .
Ligand Reports Third Quarter 2022 Financial Results.
Expect FY22 Total Revenue of $184 Million to $189 Million.
Revenue for the Third Quarter of 2022 Was $66.1 Million, Compared With $64.8 Million for the Same Period in 2021.
Q3 Earnings per Share View $0.43, Revenue View $38.3 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $43.66 Million
Adjusted EPS is expected to be $0.67

Next Quarter Revenue Guidance is expected to be $23.82 Million
Next Quarter EPS Guidance is expected to be $0.41

More details on our Analysts Page.